Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/22125| Title: | Control of Lymphocyte Fate, Infection, and Tumor Immunity by TCF-1. | Austin Authors: | Raghu, Dinesh;Xue, Hai-Hui;Mielke, Lisa A | Affiliation: | Iowa City Veterans Affairs Health Care System, Iowa City, IA 52246, USA School of Cancer Medicine, LaTrobe University, Heidelberg, VIC 3084, Australia Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA School of Molecular Sciences, College of Science, Health and Engineering, LaTrobe University, Bundoora, VIC 3083, Australia Cancer Immunobiology Program, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia |
Issue Date: | Dec-2019 | metadata.dc.date: | 2019-12 | Publication information: | Trends in immunology 2019; 40(12): 1149-1162 | Abstract: | T cell factor-1 (TCF-1), encoded by Tcf7, is a transcription factor and histone deacetylase (HDAC) essential for commitment to both the T cell and the innate lymphoid cell (ILC) lineages in mammals. In this review, we discuss the multifunctional role of TCF-1 in establishing these lineages and the requirement for TCF-1 throughout lineage differentiation and maintenance of lineage stability. We highlight recent reports showing promise for TCF-1 as a novel biomarker to identify recently characterized subsets of exhausted CD8+ T cells that may help to predict patient responses to immune checkpoint blockade (ICB). | URI: | http://ahro.austin.org.au/austinjspui/handle/1/22125 | DOI: | 10.1016/j.it.2019.10.006 | ORCID: | 0000-0002-8960-6222 | PubMed URL: | 31734149 | Type: | Journal Article | Subjects: | T cell T cell factor-1 TCF-1 immunotherapy innate lymphoid cell stem cell-like memory transcription factor |
|---|---|
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.